Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



MUELLER PETER Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2023 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $17.52, valued at $297.8k
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 14,500 options to buy @ $37.86, valued at $549k
05/26/2020 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $49.74, valued at $994.8k
Granted 5,000 options to buy @ $49.74, valued at $248.7k
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2019 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 1,554 shares @ $9.34, valued at $14.5k
08/23/2019 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 1,800 shares @ $8.42, valued at $15.2k
Bought 6,646 shares @ $8.83, valued at $58.7k
05/28/2019 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 14,700 options to buy @ $10.04, valued at $147.6k
12/07/2018 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 1,295 shares @ $5, valued at $6.5k
Bought 100 shares @ $5.01, valued at $501
Bought 495 shares @ $5, valued at $2.5k
Bought 6,905 shares @ $5.01, valued at $34.6k
12/06/2018 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 1,076 shares @ $5.09, valued at $5.5k
Bought 325 shares @ $5.11, valued at $1.7k
Bought 344 shares @ $5.12, valued at $1.8k
Bought 200 shares @ $5.13, valued at $1k
Bought 2,062 shares @ $5.15, valued at $10.6k
03/13/2018 4 MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 37,209 options @ $11, valued at $409.3k
06/18/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
05/16/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 500 shares @ $66.13, valued at $33.1k
Sold 6,400 shares @ $67.49, valued at $431.9k
Sold 600 shares @ $68.08, valued at $40.8k
Exercised 7,500 options to buy @ $32.16, valued at $241.2k
04/17/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,100 shares @ $60.57, valued at $127.2k
Sold 2,900 shares @ $61.53, valued at $178.4k
Sold 1,800 shares @ $62.38, valued at $112.3k
Sold 700 shares @ $63.27, valued at $44.3k
Exercised 1,750 options to buy @ $28.84, valued at $50.5k
Exercised 5,750 options to buy @ $32.16, valued at $184.9k
03/19/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 6,280 shares @ $78.19, valued at $491k
Sold 1,220 shares @ $78.78, valued at $96.1k
Exercised 7,500 options to buy @ $28.84, valued at $216.3k
02/20/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 6,867 shares @ $82.55, valued at $566.9k
Sold 633 shares @ $83.05, valued at $52.6k
Exercised 7,500 options to buy @ $28.84, valued at $216.3k
02/07/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 17,250 shares @ $0.01, valued at $172.5
Granted 51,000 options to buy @ $77.31, valued at $3.9M
01/17/2014 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 7,500 shares @ $78.67, valued at $590k
Exercised 7,500 options to buy @ $28.84, valued at $216.3k
12/17/2013 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 5,400 shares @ $64.4, valued at $347.8k
Sold 2,100 shares @ $65.42, valued at $137.4k
Exercised 7,500 options to buy @ $28.84, valued at $216.3k
12/12/2013 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,900 shares @ $65.48, valued at $189.9k
11/19/2013 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 1,100 shares @ $61.58, valued at $67.7k
Sold 4,200 shares @ $62.62, valued at $263k
Sold 2,200 shares @ $63.12, valued at $138.9k
Exercised 3,000 options to buy @ $18.93, valued at $56.8k
Exercised 4,500 options to buy @ $28.84, valued at $129.8k
10/17/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
08/01/2013 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 34,000 options @ $83.36, valued at $2.8M
07/17/2013 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 4,965 shares @ $86.17, valued at $427.8k
Sold 2,535 shares @ $86.66, valued at $219.7k
Exercised 7,500 options @ $18.93, valued at $142k
10/16/2012 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 4,500 shares @ $52.83, valued at $237.7k
Sold 2,000 shares @ $53.14, valued at $106.3k
Exercised 6,500 options to buy @ $16.32, valued at $106.1k
09/19/2012 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 6,500 shares @ $57.52, valued at $373.9k
Exercised 6,500 options to buy @ $16.32, valued at $106.1k
08/17/2012 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,400 shares @ $53.84, valued at $129.2k
Sold 4,100 shares @ $54.3, valued at $222.6k
Exercised 6,500 options to buy @ $16.32, valued at $106.1k
07/26/2012 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 36,250 options to buy @ $48.74, valued at $1.8M
06/19/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
05/16/2012 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,100 shares @ $63.84, valued at $134.1k
Sold 3,700 shares @ $64.3, valued at $237.9k
Sold 700 shares @ $65.5, valued at $45.9k
Exercised 6,500 options @ $16.32, valued at $106.1k
09/21/2011 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 25,000 shares @ $52.5, valued at $1.3M
Exercised 18,000 options @ $17.16, valued at $308.9k
Exercised 7,000 options @ $18.93, valued at $132.5k
08/30/2011 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 9,500 shares @ $45.01, valued at $427.6k
Exercised 4,300 options @ $10.41, valued at $44.8k
Exercised 5,200 options @ $11.27, valued at $58.6k
07/18/2011 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,500 shares @ $50.68, valued at $126.7k
Exercised 2,500 options @ $10.41, valued at $26k
07/14/2011 4 MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 36,250 options @ $51.75, valued at $1.9M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy